JXSL2500085 | PF-08046047 | PF-08046047 | Injection | Biological Products(1) | Import Drug Application | 2025-05-30 | | Pfizer Inc;Pfizer Investment Co Ltd | | | view |
JXSB2500028 | PF-08046047 | PF-08046047 | Injection | Biological Products(1) | Supplementary Application | 2025-03-29 | | BSP Pharmaceuticals SpA;Seagen Inc | | | view |
JXSB2400172 | PF-08046047 | PF-08046047 | Injection | Biological Products(1) | Supplementary Application | 2024-12-20 | | BSP Pharmaceuticals SpA;Seagen Inc | | | view |
JXSL2400182 | PF-08046047 | PF-08046047 | Injection | Biological Products(1) | Import Drug Application | 2024-09-26 | | Seagen Inc;Pfizer Investment Co Ltd | | | view |